Skip to content
10-Q

Quarterly Report

Ensysce Biosciences, Inc. ENSC ENSCW

0001493152-25-023498

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 3.54M sh
Stock Issued Q3 2025 · Sep 30, 2025 360.19K sh
Shares Diluted Q3 2025 · Sep 30, 2025 2.89M sh
Shares Diluted Q3 2025 · Sep 30, 2025 2.17M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 659.36K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 518.84K sh
Capex Q3 2025 · Sep 30, 2025 $123.64K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$6.28M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$6.74M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.67M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.5M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.2M
Stockholders Equity Q3 2025 · Dec 31, 2024 $3.71M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.3M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.21M
Total Liabilities Q3 2025 · Sep 30, 2025 $2.3M
Total Liabilities Q3 2025 · Dec 31, 2024 $2.22M
Current Assets Q3 2025 · Sep 30, 2025 $2.93M
Current Assets Q3 2025 · Dec 31, 2024 $5.34M
Total Assets Q3 2025 · Sep 30, 2025 $3.18M
Total Assets Q3 2025 · Dec 31, 2024 $5.6M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.29
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.42
Eps Diluted restated Q3 2025 · Sep 30, 2024 $1.00
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$8.52
Eps Basic Q3 2025 · Sep 30, 2025 −$1.29
Eps Basic Q3 2025 · Sep 30, 2025 −$3.42
Eps Basic restated Q3 2025 · Sep 30, 2024 $1.00
Eps Basic restated Q3 2025 · Sep 30, 2024 −$8.52
Rd Expense Q3 2025 · Sep 30, 2025 $2.95M
Rd Expense Q3 2025 · Sep 30, 2025 $6.76M
Rd Expense Q3 2025 · Sep 30, 2024 $1.69M
Rd Expense Q3 2025 · Sep 30, 2024 $3.42M
Operating Income Q3 2025 · Sep 30, 2025 −$3.74M
Operating Income Q3 2025 · Sep 30, 2025 −$7.46M
Operating Income Q3 2025 · Sep 30, 2024 $644.75K
Operating Income Q3 2025 · Sep 30, 2024 −$3.15M
Revenue Q3 2025 · Sep 30, 2025 $493.1K
Revenue Q3 2025 · Sep 30, 2025 $3.18M
Revenue Q3 2025 · Sep 30, 2024 $3.42M
Revenue Q3 2025 · Sep 30, 2024 $3.91M